WEBVTT

00:00:01.020 --> 00:00:03.540
Can you say screening is crucial to
identify early signs and malignancy.

00:00:03.570 --> 00:00:03.900
However,

00:00:03.900 --> 00:00:06.540
with the start of the COVID-19 pandemic
and due to the stay at home order issued

00:00:06.540 --> 00:00:09.330
in March, 2020 cancer
screening began to be delayed.

00:00:09.330 --> 00:00:11.100
As in-person clinic visits
were restricted ended.

00:00:11.100 --> 00:00:15.150
The patient's fear of contracting COVID-19
considering the necessity of routine

00:00:15.150 --> 00:00:17.280
cancer screenings for early
detection and treatment.

00:00:17.340 --> 00:00:20.070
This research will serve a purpose of
comparing the efficacy of tele-health

00:00:20.070 --> 00:00:23.160
based services during the COVID-19
pandemic versus in-person clinic,

00:00:23.160 --> 00:00:26.370
before COVID-19 to quantify the
difference in screening rates in general,

00:00:26.370 --> 00:00:27.510
and also through a social lens,

00:00:27.540 --> 00:00:31.680
examining the difference among different
races and socioeconomic classes to

00:00:31.680 --> 00:00:32.430
conduct this research,

00:00:32.430 --> 00:00:35.430
the words COVID-19 and cancer screening
rates research in both pub med and the

00:00:35.430 --> 00:00:37.770
web of science, which generated
hunted hundreds of results.

00:00:38.100 --> 00:00:41.220
These results were examined by both
investigators to see if they met the

00:00:41.220 --> 00:00:42.210
following inclusion criteria,

00:00:42.210 --> 00:00:46.440
which included being published in 2021
and conducted in United States. Also,

00:00:46.440 --> 00:00:49.110
the articles could not include
co-morbidities of cancer and COVID-19,

00:00:49.110 --> 00:00:52.410
or have patients with a history of cancer
because that would affect the rates of

00:00:52.410 --> 00:00:55.320
adherence cancer screenings.
Overall 36 articles were,

00:00:55.500 --> 00:00:58.680
were fully reviewed and of
the 36 8 remain in our study.

00:00:59.520 --> 00:01:00.060
Overall,

00:01:00.060 --> 00:01:03.810
the findings of all six studies concerning
breast cancer screening showed a

00:01:03.810 --> 00:01:07.410
statistically significant overall
decrease in breast cancer screening rates

00:01:07.650 --> 00:01:12.390
within 95% confidence interval of the
five studies that cover colorectal cancer

00:01:12.390 --> 00:01:12.870
screenings,

00:01:12.870 --> 00:01:17.490
four of them found a statistically
significant decrease in colorectal cancer

00:01:17.490 --> 00:01:21.660
screening rates during the COVID-19
outbreak with a 95% confidence interval,

00:01:22.020 --> 00:01:25.380
both studies regarding cervical cancer
screening showed a statistically

00:01:25.380 --> 00:01:28.020
significant decrease in
cervical cancer screening.

00:01:28.020 --> 00:01:32.790
During the peak of COVID-19 with a
95% confidence interval factors such

00:01:32.790 --> 00:01:37.290
as race or ethnicity were independently
associated with a higher risk of

00:01:37.290 --> 00:01:40.890
screening mammogram
cancellation for breast cancer.

00:01:40.890 --> 00:01:45.300
After reopening from lockdown,
during COVID-19 during the study,

00:01:45.300 --> 00:01:48.960
it was shown that there was a higher rate
of cancellation amongst whites versus

00:01:48.960 --> 00:01:49.800
white patients.

00:01:50.100 --> 00:01:54.240
This could be due to the
fact that minorities face
significantly elevated rates

00:01:54.240 --> 00:01:57.090
of comorbidity when compared with whites,

00:01:57.360 --> 00:01:59.760
therefore making them more
susceptible to disease.

00:02:00.450 --> 00:02:04.530
One limitation of the site is that
it lacks raw data and only reports.

00:02:04.530 --> 00:02:08.010
The analyzed data with many of the
sources citing their results in different

00:02:08.010 --> 00:02:08.843
formats.

00:02:09.000 --> 00:02:12.720
This did not allow for a pooled result
of the overall decrease in cancer

00:02:12.720 --> 00:02:15.000
screening rates. And in conclusion,

00:02:15.030 --> 00:02:19.440
our hypothesis was supported and that
the COVID-19 pandemic contributed to a

00:02:19.440 --> 00:02:23.580
decrease in fulfillment of the amount
of breast colorectal and cervical cancer

00:02:23.580 --> 00:02:28.440
screenings ordered or
performed in patients in
comparison to cancer screenings

00:02:28.470 --> 00:02:30.090
pre COVID in the United States.